For example, METTL3 can play a carcinogenic role in HCC through YTHDF2-dependent SOCS2 posttranscriptional silencing [50], and stabilization of BLACAT1 expression through RBMX promotes HCC development and drug resistance [51]. This evidence concerns the gene METTL3 and hepatocellular carcinoma.